Importantly, GDNF is robustly secreted by fibroblasts in the tumor environment upon treatment-induced DNA damage, which can promote prostate cancer cell proliferation and may act as a feedback mechanism contributing to treatment resistance (Huber et al., 2015). Here, GDNF is linked to prostate cancer.